Old Web
English
Sign In
Acemap
>
authorDetail
>
Wenpeng Cai
Wenpeng Cai
Anhui University of Science and Technology
Cancer research
Sorafenib
PI3K/AKT/mTOR pathway
Protein kinase B
MAPK/ERK pathway
3
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
2021
Molecular Medicine Reports
Ruyue Xu
Yinci Zhang
Amin Li
Yongfang Ma
Wenpeng Cai
Li Song
Yinghai Xie
Shuping Zhou
Weiya Cao
Xiaolong Tang
Show All
Source
Cite
Save
Citations (2)
hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway.
2020
Nanoscale Research Letters
Jing Shen
Wenpeng Cai
Yongfang Ma
Ruyue Xu
Zhen Huo
Li Song
Xinyin Qiu
Yinci Zhang
Amin Li
Weiya Cao
Shuping Zhou
Xiaolong Tang
Show All
Source
Cite
Save
Citations (4)
BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
2019
American Journal of Translational Research
Amin Li
Rongbo Zhang
Yinci Zhang
Xueke Liu
Ruikai Wang
Jiachang Liu
Xinkuang Liu
Yinghai Xie
Weiya Cao
Ruyue Xu
Yongfang Ma
Wenpeng Cai
Binquan Wu
Shuyu Cai
Xiaolong Tang
Show All
Source
Cite
Save
Citations (16)
1